AMP-Activated Protein Kinase as a Potential Anti-Diabetes Drug Target

Author(s): T. Leff.

Journal Name: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents

Volume 5 , Issue 5 , 2005

Become EABM
Become Reviewer


AMP-activated protein kinase (AMPK) is the key component of a regulatory system that senses changes in cellular energy status (AMP:ATP ratio) and modifies multiple catabolic and anabolic pathways to re-establish proper ATP concentrations. Recent findings have also indicated a significant role for the kinase in regulating whole body energy metabolism including many of the parameters that are defective in type 2 diabetes. In fact, a large body of evidences suggests that pharmacological activation of the kinase could have multiple beneficial effects with regard to the metabolic abnormalities associated with diabetes. This review provides a brief overview of how AMPK regulates glucose and fat metabolism and how activation of the kinase might affect the metabolic abnormalities of type 2 diabetes. In addition, an update is provided on the small number of novel AMPK activators that have recently been generated from targeted drug discovery programs.

Keywords: type diabetes, antidiabetic agents, ampk activators, energy balance, dephosphorylation, drug target

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [451 - 457]
Pages: 7
DOI: 10.2174/156801305774322466
Price: $58

Article Metrics

PDF: 2